The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Biomarkers, 2021Autoimmune Targeting of Mitochondria as a New Biomarker for Parkinson’s Disease
Study Rationale:
Parkinson’s disease (PD) is a complex, age-related disorder for which there are currently no biomarkers available to diagnose or predict the onset of disease. However, growing... -
Research Grant Supplement, 2021The Role of LRRK2 in the Accumulation and Spread of Tau Protein
Study Rationale:
Although most cases of Parkinson’s disease (PD) have no known genetic cause, a subset is driven by mutations in a gene called LRRK2 (leucine-rich repeat kinase 2). Further, evidence... -
Environmental Risk Factors, 2021Nationwide Geographic Cluster Analysis of Incident Parkinson’s Disease
Study Rationale:
The causes of Parkinson’s disease (PD) are mostly unknown, but non-genetic factors, such as environmental exposures during one’s lifetime, probably affect whether a person develops PD... -
Environmental Risk Factors, 2021Exposure to Ambient Air Pollution and Risk of Parkinson’s Disease
Study Rationale:
Ambient (outdoor) air pollution can increase the risk of cardiovascular diseases and death. Some evidence links ambient air pollution to higher risk of Parkinson’s disease. But... -
Research Grant, 2021Use of LRRK2 and Lysosomal Biomarker Signatures to Differentiate Idiopathic and Monogenetic Parkinson’s Disease
Study Rationale:
As new targeted therapies for Parkinson’s disease (PD) enter clinical trials, it will be important to develop biomarkers that will allow clinicians to match people with PD with... -
Target Advancement Program, 2021Validating Genetic Modifiers that Affect Disease Onset in People with LRRK2 Mutations
Study Rationale:
Mutations in the LRRK2 gene are a genetic cause of Parkinson’s disease (PD). However, the disease risk for carriers of LRRK2 mutations varies widely. Other genes — or genetic...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.